3876 - 3900 of 9148 Results
Title
Year
- Olfaction and apathy in early idiopathic Parkinson's disease2022RESTRICTEDTitle: Olfaction and apathy in early idiopathic Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 439Issue #:Start Page: 120314End Page: 120314Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120314Citation Count: 6
- Studying cognitive function in patients with a long-standing diagnosis of SWEDD2022RESTRICTEDTitle: Studying cognitive function in patients with a long-standing diagnosis of SWEDDJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 441Issue #:Start Page: 120353End Page: 120353Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120353Citation Count: 1
-
OPENTitle: Anxiety predicts impulsive-compulsive behaviours in Parkinson's disease: Clinical relevance and theoretical implicationsJournal Name: Journal of Psychiatric ResearchPublisher: Elsevier BVVol: 148Issue #:Start Page: 220End Page: 229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychires.2022.01.052Best OA location URL: https://eprints.keele.ac.uk/id/eprint/10548/1/JPSYCHIATRRES-D-21-01527-1121%20_corrected%20proof.docxCitation Count: 3
- A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding2021OPENTitle: A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid BindingJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 433Issue #: 24Start Page: 167323End Page: 167323Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2021.167323Citation Count: 15
- Classification of Parkinson's disease based on multi-modal features and stacking ensemble learning2020RESTRICTEDTitle: Classification of Parkinson's disease based on multi-modal features and stacking ensemble learningJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 350Issue #:Start Page: 109019End Page: 109019Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jneumeth.2020.109019Citation Count: 79
-
OPENTitle: Effective R2 relaxation rate, derived from dual-contrast fast-spin-echo MRI, enables detection of hemisphere differences in iron level and dopamine function in Parkinson’s disease and healthy individualsJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 382Issue #:Start Page: 109708End Page: 109708Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jneumeth.2022.109708Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0165027022002345-ga1_lrg.jpgCitation Count: 13
- Disease course and treatment patterns in progressive supranuclear palsy: A real-world study2020RESTRICTEDTitle: Disease course and treatment patterns in progressive supranuclear palsy: A real-world studyJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 421Issue #:Start Page: 117293End Page: 117293Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117293Citation Count: 18
-
OPENTitle: Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesJournal Name: CytotherapyPublisher: Elsevier BVVol: 23Issue #: 5Start Page: 373End Page: 380Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jcyt.2021.01.001Best OA location URL: http://hdl.handle.net/11380/1251814Citation Count: 247
- Are hedge funds' charitable donations strategic?2020RESTRICTEDTitle: Are hedge funds' charitable donations strategic?Journal Name: Journal of Corporate FinancePublisher: Elsevier BVVol: 66Issue #:Start Page: 101842End Page: 101842Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jcorpfin.2020.101842Citation Count: 16
- Optimal Treatment of Depression and Anxiety in Parkinson's Disease2021RESTRICTEDTitle: Optimal Treatment of Depression and Anxiety in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 530End Page: 540Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.02.037Citation Count: 66
- The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”2021RESTRICTEDTitle: The Importance of Cross-Disciplinary Research: A Commentary on “Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson's Disease”Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 9Start Page: 969End Page: 971Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.01.010Citation Count: 0
- N-terminal acetylation does not alter α-synuclein's interfacial properties2021RESTRICTEDTitle: N-terminal acetylation does not alter α-synuclein's interfacial propertiesJournal Name: International Journal of Biological MacromoleculesPublisher: Elsevier BVVol: 174Issue #:Start Page: 69End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ijbiomac.2021.01.147Citation Count: 4
-
OPENTitle: Intracellular Thermometry to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 46Issue #: 3Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tibs.2020.12.003Best OA location URL: http://www.cell.com/article/S096800042030308X/pdfCitation Count: 2
- Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease2021RESTRICTEDTitle: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 6Start Page: 550End Page: 565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1Citation Count: 52
- Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker2022OPENTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 54
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial2021RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 138
- Aducanumab: look before leaping2021RESTRICTEDTitle: Aducanumab: look before leapingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 9Start Page: 1499End Page: 1499Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5Citation Count: 13
- Deep brain stimulation for obsessive–compulsive disorder: a crisis of access2022OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 81
-
OPENTitle: Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gapJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 4Issue #: 11Start Page: e768End Page: e769Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(22)00190-xBest OA location URL: http://www.thelancet.com/article/S258975002200190X/pdfCitation Count: 4
-
OPENTitle: Thyrotoxicosis Resulting in Unilateral Upper Limb Chorea and BallismusJournal Name: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesPublisher: Cambridge University Press (CUP)Vol: 49Issue #: 3Start Page: 431End Page: 432Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/cjn.2021.136Citation Count: 3
-
OPENTitle: Prehospital scales in acute ischaemic stroke management – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 504End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00169-1Best OA location URL: https://pure.eur.nl/en/publications/25abb6f2-0472-4754-8580-97e2533ac37aCitation Count: 1
-
OPENTitle: The Records of the Human Sciences Research CouncilJournal Name: History in AfricaPublisher: Cambridge University Press (CUP)Vol: 48Issue #:Start Page: 397End Page: 411Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/hia.2021.15Citation Count: 1
-
OPENTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 137
- Movement disorders research in 2021: cracking the paradigm2021RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 19
- Revisiting levodopa for advanced Parkinson's disease2022RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 2
